Basit öğe kaydını göster

dc.contributor.authorSaricaoglu, Fatma
dc.contributor.authorUzun, Sennur
dc.contributor.authorArun, Oguzhan
dc.contributor.authorArun, Funda
dc.contributor.authorAypar, Ulku
dc.date.accessioned2019-12-12T06:49:20Z
dc.date.available2019-12-12T06:49:20Z
dc.date.issued2011
dc.identifier.issn1658-354X
dc.identifier.urihttps://doi.org/10.4103/1658-354X.76509
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101756/
dc.identifier.urihttp://hdl.handle.net/11655/17129
dc.description.abstractObjective: The purpose of this study was to compare etomidate-lipuro and propofol and 50%, (1:1) admixture of these agents at induction with special reference to injection pain, hemodynamic changes, and myoclonus. Methods: Ninety patients were assigned at random to three groups in which induction was performed with either etomidate-lipuro, propofol or etomidate-lipuro–propofol admixture. After monitorization with bispectral index (BIS) all agents were given with infusion with a perfuser at a constant rate of 200 ml/min till the BIS values decreased to 40. Blood pressure and heart rate were measured every 30 s at this period. Patients were asked for pain at the injection site and observed visually for myoclonus. The time BIS values decreased to 40 (BIS 40 time) and total amounts of induction doses were measured. Results: BIS 40 time measurements were P > E > PE (199.4 ± 40.9, 176.9 ± 31.6, 163.5 ± 20.6 s). The hemodynamic (systolic, diastolic and mean blood pressures, heart rate) changes were minimal in group PE than other two groups (P = 0.017). The intensity of myoclonus was graded as mild in 9, moderate in 12, and severe in 5 patients in the group E (76.3%). Myoclonus was not observed in group PE and group P. There were no injection pain in group PE as the incidence were (83.8%) in group P and in (63.2%) group E. Conclusion: Incidence of hemodynamic changes, myoclonus, and injection pain is significantly lower in group PE. BIS 40 times is least in group PE. We concluded that 1:1 admixture of etomidate-lipuro and propofol is a valuable agent for induction.
dc.relation.isversionof10.4103/1658-354X.76509
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleA Clinical Comparison of Etomidate-Lipuro, Propofol and Admixture at Induction
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalSaudi Journal of Anaesthesia
dc.contributor.departmentAnesteziyoloji ve Reanimasyon
dc.identifier.volume5
dc.identifier.issue1
dc.identifier.startpage62
dc.identifier.endpage66
dc.description.indexPubMed
dc.description.indexScopus


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster